comparemela.com

Latest Breaking News On - Danielle brill - Page 8 : comparemela.com

Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript

SRPT earnings call for the period ending March 31, 2023.

United statesKristen kluska cantor fitzgeraldDanielle brillJudah frommerDoug ingramBrian skorneyHartaj singhIan estepanAnupam ramaGena wang barclaysJoseph schwartzSalveen richter goldman sachsShu zhiqiang berenbergWilliam blairKristen kluskaTim lugo william blair

Harmony Biosciences (HRMY) Q1 2023 Earnings Call Transcript

HRMY earnings call for the period ending March 31, 2023.

United kingdomJeff dierksCorinne jenkins goldman sachsCorinne jenkinsFrancois briseboisDavid amsellemCharles duncan cantor fitzgeraldBrisebois oppenheimerFadia needhamSandip kapadiaAmerica merrill lynchRaymond jamesCharles duncanJason gerberryPiper sandlerJeffrey dayno

Stuart Peltz, founder of PTC, retires after 25 years as CEO

BioPharma

United statesMatthew kleinStuart peltzRaymond jamesDanielle brillMarathon pharmaceuticalsHealthcare conference

Sarepta Therapeutics (SRPT) Q4 2022 Earnings Call Transcript

SRPT earnings call for the period ending December 31, 2022.

Hartaj singhAnupam rama jpmorganHartaj singh oppenheimerRaymond jamesGena wangJerry mendellLouise rodino klapacDanielle brill raymond jamesGena wang barclaysSalveen richterDoug ingramKristen kluskaMatthew harrison morgan stanleyBaral cowenRick miller cantor fitzgeraldJoe schwartz

Raymond James Reaffirms Their Buy Rating on uniQure (QURE)

In a report released yesterday, Danielle Brill from Raymond James maintained a Buy rating on uniQure (QURE – Research Report), with a pric.

Noord hollandDanielle brillRaymond jamesResearch reportStrong buy

vimarsana © 2020. All Rights Reserved.